Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
taj doctor unit
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
  Betahistine hydrochloride Tablet  
HOME >> PRODUCTS >> Generic Medicines >> Taj Generics >> Page 6 >> Betahistine hydrochloride Tablet
   Betahistine hydrochloride
   Tablet
 

 

 


Each Tablet contains:
     Betahistine dihydrochloride tablets............................ 16 mg

COMPOSITION :
Betahistine dihydrochloride ..  8mg Tablets.
Betahistine dihydrochloride ..16mg Tablets.
Betahistine dihydrochloride ..
24mg Tablets.
Betahistine dihydrochloride ..32mg Tablets.

      For more information, please see Full Prescribing Information.

INDICATIONS :
Betahistine dihydrochloride  may be of value in reducing the episodes of vertigo in Meniere's disease.

DOSAGE AND ADMINISTRATION :
The usual adult dosage has been one to two tablets (4mg. each) administered orally three times a day. The dosage has ranged from two tablets per day to eight tablets per day. No more than eight tablets are recommended to be taken in any one day.

Betahistine hydrochloride is not recommended for use in children. As with all drugs, Betahistine hydrochloride should be kept out of reach of children.

CONTRAINDICATIONS :
Several patients with a history of peptic ulcer have experienced an exacerbation of symptoms while using Betahistine dihydrochloride . Although no causal relation has been established betahistine hydrochloride is contraindicated in the presence of peptic ulcer and in patients with a history of this condition.
 

Betahistine Hydrochloride

PRECAUTIONS :
Although clinical intolerance to
Betahistine dihydrochloride  by patients with bronchial asthma has not been demonstrated, caution should be exercised if the drug is used in these patients.

Betahistine dihydrochloride  should not be used concurrently with antihistamine agents since no information is available with regard to the possible interaction of these drugs.

The physician should be aware of the possibility of hitherto unreported adverse reactions to
Betahistine dihydrochloride .

USE IN PREGENANCY :
The safety of
Betahistine dihydrochloride  in pregnancy has not been established. Therefore, its use in pregnancy or lactation, or in women of child bearing age requires that its potential benefits be weighed against the possible risks.

PACKAGING INFORMATION :
Betahistine dihydrochloride  .............500tablet

Wallpapers :       Betahistine hydrochloride packing
     CLICK ON PHOTO TO SEE LARGE.



 
product enquiry product quotation sample request order now
Product Enquiry Product Quotation Sample Request Order Now
       
       
   Information about Generic Medicines   career
   Information about Manufacturing   career
 

 

Mianserin
tablets film-coated

Betahistine hydrochloride
Pharmaceuticals Generics
  (Triprolidine, Pseudoephedrine) tablets, syrup  
  (Barium sulphate) suspension  
  Water for injections  
  Trimetazidine Dihydrochloride tablet  
  Tamsulosin Hydrochloride 0.4 mg Capsule  
  Ramipril tablet  
  Betahistine hydrochloride
Tablet
 
  Clopidogrel tablet  
  Fenofibrate Capsule  
  Lamotrigine 50mg / 100mg Tablets  
  Topiramate Tablets  
 

More..

 



          
 Print page   Send by mail

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`
























 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 www.tajpharma.com

   

   

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement